Literature DB >> 15554621

[Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents.

Silvio Aime1, Luisella Calabi, Camilla Cavallotti, Eliana Gianolio, Giovanni B Giovenzana, Pietro Losi, Alessandro Maiocchi, Giovanni Palmisano, Massimo Sisti.   

Abstract

An innovative MRI contrast agent based on the unprecedented and easily obtained ligand AAZTA is described. The simple and straightforward synthesis of the ligand, together with the potentiometric and relaxometric behavior of the corresponding Gd(III) chelate, is reported. The complex [Gd(AAZTA)]- shows outstanding magnetic properties connected with high thermodynamic stability in aqueous solution and a nearly complete inertness toward the influence of bidentate endogenous anions, placing this compound as one of the most promising candidates for the development of high performance MRI contrast agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15554621     DOI: 10.1021/ic0489692

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  34 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

2.  Tri-tert-butyl 3-oxo-4-oxa-1,8,11-triazaspiro[5.6]dodecane-1,8,11-triacetate.

Authors:  Raghvendra Singh Sengar; Steven J Geib; Archana Nigam; Erik C Wiener
Journal:  Acta Crystallogr C       Date:  2010-03-06       Impact factor: 1.172

3.  High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation.

Authors:  Matthew W Rotz; Kayla S B Culver; Giacomo Parigi; Keith W MacRenaris; Claudio Luchinat; Teri W Odom; Thomas J Meade
Journal:  ACS Nano       Date:  2015-03-24       Impact factor: 15.881

4.  Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles.

Authors:  Simonetta Geninatti Crich; Stefania Lanzardo; Diego Alberti; Simona Belfiore; Anna Ciampa; Giovanni B Giovenzana; Clara Lovazzano; Roberto Pagliarin; Silvio Aime
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

Review 5.  Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.

Authors:  Ching-Hui Huang; Andrew Tsourkas
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 6.  Basic MR relaxation mechanisms and contrast agent design.

Authors:  Luis M De León-Rodríguez; André F Martins; Marco C Pinho; Neil M Rofsky; A Dean Sherry
Journal:  J Magn Reson Imaging       Date:  2015-05-14       Impact factor: 4.813

7.  Analytical methods for characterizing magnetic resonance probes.

Authors:  Lisa M Manus; Renee C Strauch; Andy H Hung; Amanda L Eckermann; Thomas J Meade
Journal:  Anal Chem       Date:  2012-05-23       Impact factor: 6.986

8.  Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.

Authors:  Peter Caravan; Christian T Farrar; Luca Frullano; Ritika Uppal
Journal:  Contrast Media Mol Imaging       Date:  2009 Mar-Apr       Impact factor: 3.161

Review 9.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

10.  Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.

Authors:  Eszter Boros; Miloslav Polasek; Zhaoda Zhang; Peter Caravan
Journal:  J Am Chem Soc       Date:  2012-11-16       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.